PETQuant: Neurodegenerative Assessment in Clinical Research

June 9, 2016
< 1 mins

Category: Case studies
Product: NeuroQuant PET

Dr. James Brewer, MD, PhD, Neurologist, UC San Diego, hosted a live webinar from our our San Diego headquarters entitled: PETQuant™: Neurodegenerative Dementia Assessment in Research. Dr. Brewer gave a fascinating and enlightening presentation about using PETQuant in clinical research and covered many topics in the video below, including:

Why patient native brain space is important in PET imaging
The value of quantifying brain structure volumes (via NeuroQuant®)
How PETQuant can simplify the process of interpreting PET scans
Several case studies

PETQuant is our recently launched for research only tool that provides brain segmentation using PET imaging studies to quantify subregional tracer binding in native brain space for FDG and Florbetapir.

If you would like more information about using PETQuant in your clinical research, please contact us.

Topic: Case studies

More Resources

08/18/2025

Why Bigger Normative Databases Mean Better Brain Imaging

NeuroQuant® 5.2 compares patient brain MRI volumes to over 7,000 healthy scans, giving clinicians clear, percentile-based context for better assessments.

Blogs

08/07/2025

Navigating Reimbursement for NeuroQuant: Understanding CPT Codes 0865T & 0866T

Let’s break down the latest category III CPT codes and example clinical use cases that illustrate their value.

Blogs

07/31/2025

Precision Without the Pressure: Smarter Brain Tumor Monitoring

Learn about NeuroQuant Brain Tumor 2.0 and how it assists clinicians by providing objective quantification and analysis of tumor changes over time.

Blogs

07/30/2025

Cortechs.ai Announce Next-Gen NeuroQuant Brain Tumor: AI-Driven Metastasis & Meningioma Segmentation

NeuroQuant Brain Tumor is the first FDA-cleared, cloud-native tool to offer automated volumetric segmentation for brain metastases, meningiomas, and gliomas.

Cortechs.ai news

07/28/2025

Longitudinal Assessment of Traumatic Brain Injury Using NeuroQuant®

A case study with Dr. Suzie Bash on NeuroQuant as a reliable, reimbursable, and efficient tool in the evaluation and follow-up of TBI.

Case studies

07/24/2025

Understanding the Hippocampal Occupancy Score

One of the most frequently asked questions among customers is, “What does the Hippocampal Occupancy Score (HOC) represent within the Dementia Report?”

Our solutions

Our solutions

About

Support

Resources